[Paramethoxymethamphetamine].
Avdeling for klinisk farmakologi, St. Olavs Hospital, Norway. andreas.westin@legemidler.no
Andreas Austgulen
AA
Westin
Wenche Rødseth
WR
Brede
D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D000697:Central Nervous System Stimulants / Q000008:administration & dosage* / Q000009:adverse effects; D006213:Hallucinogens / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D013287:Illicit Drugs / Q000009:adverse effects; D008297:Male; D008694:Methamphetamine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000008:administration & dosage / Q000009:adverse effects; D012640:Seizures / Q000139:chemically induced
D000697:Central Nervous System Stimulants; D006213:Hallucinogens; D013287:Illicit Drugs; C106885:paramethoxymethamphetamine; D008694:Methamphetamine; D018817:N-Methyl-3,4-methylenedioxyamphetamine